Summary

Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its own tissues and organs. Sepsis can lead to multiple organ failure and death, especially if it is not recognized early and treated promptly (Elfeky et al., 2017; Mayo Clinic, 2016). Anyone can develop sepsis; however, the condition is more common among children less than one year of age, older adults, and those with weakened immune systems (Elfeky et al., 2017; Mayo Clinic, 2016).

In men and women, among the 7MM in 2016, the US had the highest age-standardized diagnosed incidence of sepsis and Japan had the lowest. In the 5EU (France, Germany, Italy, Spain, UK), the age-standardized diagnosed incidence of sepsis in men ranged between 94.91 cases per 100,000 population in France and 174.05 cases per 100,000 population in the UK in 2016. The age-standardized diagnosed incidence of sepsis in women in the 5EU ranged between 36.76 cases per 100,000 population in France and 128.05 cases per 100,000 populations in the UK in 2016. Due to data scarcity, the crude diagnosed incidence of sepsis for Italy is considered to be same as that of Spain and therefore the calculated age-standardized diagnosed incidence rates are also similar in these markets.

Among the 7MM, in men and women in 2016, the US had the highest age-standardized diagnosed incidence of septic shock and Japan had the lowest. In the 5EU, the age-standardized diagnosed incidence of sepsis in men ranged between 29.55 cases per 100,000 population in Germany and 52.57 cases per 100,000 population in the UK in 2016. Similarly, the age-standardized diagnosed incidence of septic shock in women in the 5EU ranged between 11.56 cases per 100,000 population in France and 38.86 cases per 100,000 population in the UK in 2016. Due to data scarcity, the crude diagnosed incidence of septic shock for Italy is considered to be same as that of Spain and therefore, the calculated age-standardized diagnosed incidence rates are also similar in these markets.

The report "EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026", provides an overview of the risk factors, comorbidities, and the global and historical trends for sepsis and septic shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, segmented by sex and by age (for all ages).

In depth, this report provides the following -

  • The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.




Scope

  • The Sepsis and Septic Shock EpiCast Report provides an overview of the risk factors and global trends of sepsis and septic shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, segmented by age (for all ages) and sex. The sepsis and septic shock diagnosed incident cases are further segmented by causative agent and organ dysfunction. Additionally, GlobalData epidemiologists provide a forecast for the in-hospital mortality cases of sepsis and septic shock, segmented by age for both sexes.
  • The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.




Reasons To Buy

The Sepsis and Septic Shock EpiCast report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global sepsis and septic shock market.
  • Quantify patient populations in the global sepsis and septic shock market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis and septic shock therapeutics in each of the markets covered.
  • Understand the causative agent, organ dysfunction, and mortality of sepsis and septic shock.